146 related articles for article (PubMed ID: 8803685)
1. Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption.
Wallukat G; Reinke P; Dörffel WV; Luther HP; Bestvater K; Felix SB; Baumann G
Int J Cardiol; 1996 May; 54(2):191-5. PubMed ID: 8803685
[TBL] [Abstract][Full Text] [Related]
2. Specific removal of beta1-adrenoceptor autoantibodies by immunoabsorption in rabbits with autoimmune cardiomyopathy improved cardiac structure and function.
Matsui S; Larsson L; Hayase M; Katsuda S; Teraoka K; Kurihara T; Murano H; Nishikawa K; Fu M
J Mol Cell Cardiol; 2006 Jul; 41(1):78-85. PubMed ID: 16780870
[TBL] [Abstract][Full Text] [Related]
3. Ig-Therasorb immunoadsorption for selective removal of human immunoglobulins in diseases associated with pathogenic antibodies of all classes and IgG subclasses, immune complexes, and fragments of immunoglobulins.
Koll RA
Ther Apher; 1998 May; 2(2):147-52. PubMed ID: 10225717
[TBL] [Abstract][Full Text] [Related]
4. Acute hemodynamic effects during immunoadsorption in patients with dilated cardiomyopathy positive for beta 1-adrenoceptor autoantibodies.
Christ T; Dobrev D; Wallukat G; Schüler S; Ravens U
Methods Find Exp Clin Pharmacol; 2001 Apr; 23(3):141-4. PubMed ID: 11523313
[TBL] [Abstract][Full Text] [Related]
5. Immunoadsorption in dilated cardiomyopathy.
Dörffel WV; Wallukat G; Baumann G; Felix SB
Ther Apher; 2000 Jun; 4(3):235-8. PubMed ID: 10910026
[TBL] [Abstract][Full Text] [Related]
6. Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus.
Dandel M; Englert A; Wallukat G; Riese A; Knosalla C; Stein J; Hetzer R
Atheroscler Suppl; 2015 May; 18():124-33. PubMed ID: 25936316
[TBL] [Abstract][Full Text] [Related]
7. Ig apheresis for the treatment of severe DCM patients.
Pokrovsky SN; Ezhov MV; Safarova MS; Saidova MA; Shitov VN; Afanasieva MI; Khaustov AI; Adamova IY; Afanasieva OI; Konovalov GA
Atheroscler Suppl; 2013 Jan; 14(1):213-8. PubMed ID: 23357167
[TBL] [Abstract][Full Text] [Related]
8. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy.
Staudt A; Böhm M; Knebel F; Grosse Y; Bischoff C; Hummel A; Dahm JB; Borges A; Jochmann N; Wernecke KD; Wallukat G; Baumann G; Felix SB
Circulation; 2002 Nov; 106(19):2448-53. PubMed ID: 12417541
[TBL] [Abstract][Full Text] [Related]
9. Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.
Dandel M; Wallukat G; Englert A; Lehmkuhl HB; Knosalla C; Hetzer R
Eur J Heart Fail; 2012 Dec; 14(12):1374-88. PubMed ID: 22892122
[TBL] [Abstract][Full Text] [Related]
10. [Apheresis of immunoglobulins - new approach to the treatment of severe dilated cardiomyopathy].
Konovalov GA; Belenkov IuN; Zvezdkin PV; Chebyshev AN; Semin SN; Kuznetsova IuV; Adamova IIu; Kipor SG; Pokrovskiĭ SN
Kardiologiia; 2002; 42(6):92-6. PubMed ID: 12494138
[TBL] [Abstract][Full Text] [Related]
11. Agonist-like beta-adrenoceptor antibodies in heart failure.
Wallukat G; Müller J; Podlowski S; Nissen E; Morwinski R; Hetzer R
Am J Cardiol; 1999 Jun; 83(12A):75H-79H. PubMed ID: 10750592
[TBL] [Abstract][Full Text] [Related]
12. Functional autoantibody diseases: Basics and treatment related to cardiomyopathies.
Becker NP; Goettel P; Mueller J; Wallukat G; Schimke I
Front Biosci (Landmark Ed); 2019 Jan; 24(1):48-95. PubMed ID: 30468647
[TBL] [Abstract][Full Text] [Related]
13. Immunoadsorption therapy for dilated cardiomyopathy using tryptophan column-A prospective, multicenter, randomized, within-patient and parallel-group comparative study to evaluate efficacy and safety.
Yoshikawa T; Baba A; Akaishi M; Wakabayashi Y; Monkawa T; Kitakaze M; Izumi T; Tomoike H
J Clin Apher; 2016 Dec; 31(6):535-544. PubMed ID: 26801483
[TBL] [Abstract][Full Text] [Related]
14. Aptamer BC007 for neutralization of pathogenic autoantibodies directed against G-protein coupled receptors: A vision of future treatment of patients with cardiomyopathies and positivity for those autoantibodies.
Wallukat G; Müller J; Haberland A; Berg S; Schulz A; Freyse EJ; Vetter R; Salzsieder E; Kreutz R; Schimke I
Atherosclerosis; 2016 Jan; 244():44-7. PubMed ID: 26584137
[TBL] [Abstract][Full Text] [Related]
15. [Immunoadsorption in a patient with dilated cardiomyopathy. The first case in Hungary].
Soltész P; Vass M; Diószegi Á; Mányiné Siket I; Garai I; Kun C; Bene O; Kertész A; Édes I
Orv Hetil; 2018 Apr; 159(13):526-530. PubMed ID: 29577764
[TBL] [Abstract][Full Text] [Related]
16. Peptide based adsorbers for therapeutic immunoadsorption.
Rönspeck W; Brinckmann R; Egner R; Gebauer F; Winkler D; Jekow P; Wallukat G; Müller J; Kunze R
Ther Apher Dial; 2003 Feb; 7(1):91-7. PubMed ID: 12921122
[TBL] [Abstract][Full Text] [Related]
17. Successful and well-tolerated bi-weekly immunoadsorption regimen in pemphigus vulgaris.
Dietze J; Hohenstein B; Tselmin S; Julius U; Bornstein SR; Beissert S; Günther C
Atheroscler Suppl; 2017 Nov; 30():271-277. PubMed ID: 29096849
[TBL] [Abstract][Full Text] [Related]
18. Immunoadsorption in idiopathic dilated cardiomyopathy, a 3-year follow-up.
Dörffel WV; Wallukat G; Dörffel Y; Felix SB; Baumann G
Int J Cardiol; 2004 Dec; 97(3):529-34. PubMed ID: 15561344
[TBL] [Abstract][Full Text] [Related]
19. Non-specific removal of antibodies in patients with idiopathic dilated cardiomyopathy: implications for xenotransplantation.
Knosalla C; Müller J; Moran K; Wallukat G; Hetzer R; Cooper DK
J Heart Lung Transplant; 2004 May; 23(5):623-6. PubMed ID: 15135381
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of immunoadsorption and subsequent immunoglobulin substitution in patients with dilated cardiomyopathy: Results from the observational prospective Bad Berka Registry.
Ohlow MA; Brunelli M; Schreiber M; Lauer B
J Cardiol; 2017 Feb; 69(2):409-416. PubMed ID: 27890513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
